A phase I/II trial of tertomotide (GV 1001), without concomitant chemotherapy or radiotherapy, in patients with advanced non-small cell lung cancer.
Phase of Trial: Phase I/II
Latest Information Update: 17 Nov 2011
At a glance
- Drugs Tertomotide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 17 Nov 2011 New trial record
- 15 Nov 2011 An 8-year update from this trial has been published in the November issue of Clinical Cancer, according to a KAEL-GemVax media release.